Adaptimmune Therapeutics PLC (ADAP)
0.6048
0.00 (0.00%)
USD |
NASDAQ |
Dec 20, 16:00
0.5958
-0.01
(-1.49%)
After-Hours: 20:00
Adaptimmune Therapeutics Profit Margin (Quarterly): -43.07% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -67.80% |
| Return on Assets | -15.08% |
| Return on Invested Capital | -55.22% |
| Operating Margin (Quarterly) | -35.89% |
| Return on Net Operating Assets | -37.82% |